Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cell Lines Available for Research

By Biotechdaily staff writers
Posted on 23 Oct 2005
Nine cell lines are available to commercial and academic researchers worldwide who are seeking a cure for lymphoma, leukemia, pancreatic cancer, or macroglobulinema.

The cell lines were developed by researchers at the Barbara Ann Karmanos Cancer Institute of Wayne State University (Detroit, MI, USA) and are being distributed by Asterand, Inc. More...
(Detroit, MI, USA; www.asterand.com). Asterand also markets breast cancer cell lines under license from the University of Michigan (Ann Arbor, USA) and prostate cancer lines from Onyvax (London, UK). The company acquires donated samples from a world-wide network of collaborating hospitals and clinics.

Following are the cell lines available: Waldenstrom's macroglobulinema, follicular small cleaved cell lymphoma, diffuse large cell lymphoma (chemo-resistant), acute lymphoblastic leukemia (early stage), acute myeloid leukemia, pancreatic cancer, diffuse large cell lymphoma, Burkitt's lymphoma, and nodal histiocytic lymphoma (intermediate grade).

"These cell lines are very good model systems for diseases they are derived from,” said Dr. James Eliason, chief scientific officer of Asterand. "They have been studied extensively by researchers at Wayne State University and elsewhere, which is evident by the fact that there are over 50 publications related to them. In addition to common cancers, these cell lines are great resources for studying rare cancers such as Burkitt's lymphoma, which affects children and young people, aged 12-30, or pancreatic cancer, which is probably one of the most difficult cancers to detect.”




Related Links:
Asterand

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.